Class II Alloantibody and Mortality in Simultaneous Liver-Kidney Transplantation
Version of Record online: 22 FEB 2013
© Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons
American Journal of Transplantation
Volume 13, Issue 4, pages 954–960, April 2013
How to Cite
O'Leary, J. G., Gebel, H. M., Ruiz, R., Bray, R. A., Marr, J. D., Zhou, X. J., Shiller, S. M., Susskind, B. M., Kirk, A. D. and Klintmalm, G. B. (2013), Class II Alloantibody and Mortality in Simultaneous Liver-Kidney Transplantation. American Journal of Transplantation, 13: 954–960. doi: 10.1111/ajt.12147
- Issue online: 30 MAR 2013
- Version of Record online: 22 FEB 2013
- Manuscript Accepted: 17 DEC 2012
- Manuscript Revised: 6 DEC 2012
- Manuscript Received: 6 SEP 2012
Disclaimer: Supplementary materials have been peer-reviewed but not copyedited.
|ajt12147-sup-0001-FigureS1.jpg||82K||Figure S1: (A) Preformed class I DSA most often resolved after SLKT; however, (B) class II DSA is much more commonly persistent.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.